Selling with heart

We’re proud of what Linha Canabica became — our strongest top-of-funnel engine and a community we care about. That’s why this decision isn’t easy. But focus is a form of respect. By separating and selling the marketplace, a dedicated buyer can scale what already works, while we fully dedicate ourselves to building Hemp Vegan — advancing product R&D, lab rigor. In short: the marketplace grows in the right hands, and we return to what we do best — crafting exceptional, vegan cannabis products.

Where this started

Linha Canabica began with a simple mission: destigmatize cannabis and make informed access possible at home — via vegan, plant-based products and clear education. That early work set our compass: access, dignity, clarity.

Our origin is personal. Founder Bárbara Arranz (biomedical scientist, mother of three) pursued cannabis’ therapeutic potential for her son amid stigma, scarce information, and regulatory barriers — choosing to learn, document, and advocate responsibly.

Business overview

• Model: Online marketplace in Brazil for medicinal cannabis, connecting consumers and healthcare professionals to vetted brands and retailers.
• Education: Treatment/condition database plus user reviews to support informed purchasing decisions.
• Compliance: Seller onboarding aligned with Anvisa standards and documentation.
• Scale: 50,000+ users, ~13,000 organic visits/month, 240 healthcare professionals, 12+ EU/US brands & resellers, and 800+ direct-selling distributors.
• Team: 4 permanent employees (~$1.500); additional contract resellers (pass profit ~0.5%); remote-first operations.
• Ownership & capital: 3 owners (98% / 1% / 1%), self-funded, no debt.

Revenue model & unit economics

• Commission: 15%–30% per sale (by category/partner tier).
• Average order value: ~USD 120 (including $16~$22 shipping).
• Buyer value: Curated catalog across edibles, topicals, extracts; education that lifts conversion quality.
• Seller value: Qualified reach plus structured marketing/ordering tools to remain compliant.

Note: The Google Search snapshot reflects last month’s organic data. HubSpot dashboards document our track record since 2020, showing a fully configured sales funnel integrated with Shopify, account managers for affiliates, customers, and distributors, and inbound workflows powered by high-converting, elegantly designed emails.

Performance & audience highlights

• Historic content engine (dictionary A–Z, clinical explainers) driving sustained organic demand.
• Community and clinician engagement through events, guides, and condition-focused content.

Representative high-intent anchor content (SEO, AI Answers)

• Ecosystem Partners
• Condition & Treatment Dictionary (A–Z) — how medicinal cannabis may support diverse conditions.
• Cannabis & Diabetes (example condition page) — research roundups and user guidance.
• Research Methodology & Patient Monitoring — how we structured patient-reported outcomes.
• Brazil’s Medicinal Cannabis Card Initiative — access via medicinal card concept.
• CBD Treatment Guide  |  Full-Spectrum CBD Oil
• Vaporizers for Medicinal Cannabis, even if restricted in Brazil, those who search for vaporizers are usually the first to explore new formats. That’s why we share ideas like CBD resin or THC Shot, aligned with what prescribers already work with.
• Medicinal Cannabis Cultivation Guide
• Home Cannabis Cultivation in Brazil: Habeas Corpus DIY Guide for FREE
• Cannabis Culinary Guides
• CBD Dosage Guides

Innovation: PrescrIA project (AI clinical decision support)

PrescrIA is an educational and technical R&D experiment exploring AI as clinical decision support — with two collaborating AI agents simulating clinical decisions under structured protocols and mandatory human validation. It does not replace clinicians and does not issue real prescriptions without supervision; it explicitly respects Brazil’s ethical, legal, and regulatory boundaries. The goal is to open paths for reflection, innovation, and safer, more transparent care.

Request info→

PrescrIA Project: Two agents, one clinical decision (And why does this matter?)→

What’s included in the sale

• Brand & IP: Linha Canabica brand assets (names, logos, style), domains/social handles.
• Tech: Marketplace codebase & integrations; documentation; operational SOPs.
• Data & content: User/seller datasets (transfer under LGPD/consents), analytics, education library.
• Supply side: Onboarded sellers/brands plus the 800+ distributor network.
• Go-to-market: Organic SEO footprint, email automations, partner playbooks.

Growth opportunities for a buyer

• Supply expansion: Additional EU/US brands and Brazilian import partners; broader SKUs/price tiers.
• Clinical funnel: Telehealth/clinic partnerships where permitted for guided journeys.
• Subscriptions: Refills and condition/cannabinoid bundles to lift LTV.
• Distributor enablement: Better tooling, education, and incentives to grow GMV.
• Ops: Payments, cross-border logistics, and last-mile SLAs.

Why this matters to us (and will to you)

From day one, we prioritized people over hype: plain language, whole-plant respect, and honest access. Those values powered community growth and clinician engagement — from condition guides to patient diaries and events — and continue to guide our work.

Deal structure & process

• Structure: Asset sale or majority equity acquisition (open to strategic partnerships).
• Data room: NDA required (metrics, seller contracts, SOPs, tech overview, compliance docs).
• Transition: Negotiable handover and training for continuity.
• Compliance: Operations must follow applicable laws (incl. Anvisa, MAPA) and LGPD.

See it live — book a call

We’ll walk you through our HubSpot CRM (inbound + automations), organic analytics, keyword positions, anchor-link performance, and the 2024 P&L — in real time. If there’s a fit, we’ll proceed to NDA and data-room access.

• Seed banks & genetics marketplaces: leverage Brazil’s emerging framework for industrial hemp cultivation to consolidate brand presence and reach both B2B and B2C audiences.
• High-THC products: under RDC 660, demand is strong from patients currently reliant on community associations — a ready-made channel for expansion.
• Low-THC products: under RDC 327, Linha Canabica’s monthly organic traffic provides a first-mover advantage for compliant product distribution.
• International brands: companies looking to enter Latin America can plug directly into a trusted user base and distributor network that has already proven its ability to scale adjacent ventures.
• Healthtechs: platforms that want to expand into Brazil gain an ecosystem that already speaks the language of patients and clinicians — lowering acquisition costs and accelerating trust-building. The acquisition also includes PrescrIA, an AI clinical decision support project currently in labs, which strengthens the long-term innovation play.
• Strategic investors: for those seeking influence in media, SEO, and community, Linha Canabica offers not just a marketplace but an asset positioned for organic discovery, spontaneous press coverage, and clinical relationships.

Request info pack & NDA→

Learn more about the cannabis landscape in Brazil→

Community & Social Reach

On Instagram, we’ve built 130,000+ organic followers with high engagement. The account is temporarily deactivated; we have filed a formal legal request for reactivation after an erroneous action by Meta. On TikTok, the hashtag #linhacanabicadaba has generated 1.5M+ mentions, underscoring strong brand awareness and user-generated content.